LDL-Cholesterol: From the Hypothesis to Causality

被引：6

作者：

Custodis, Florian ^{[1
]}

Laufs, Ulrich ^{[1
]}

机构：

[1] Univ Klinikum Saarlandes, Abt Innere Med Kardiol Angiol & Internist Intensi, Homburg, Germany

来源：

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2015年 / 140卷 / 10期

关键词：

LDL; Cholesterol; LDL-Hypothesis; IMPROVE-IT; CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; IMPROVE-IT; TRIALS; RISK; HYPERCHOLESTEROLEMIA; METAANALYSIS; SIMVASTATIN; PREVENTION; REDUCTION;

D O I：

10.1055/s-0041-102254

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The term "LDL-Hypothesis is frequently used to describe the association between LDL cholesterol (LDL-C) and cardiovascular outcomes. In the light of recent results of randomized trials the question arises whether the term hypothesis is still adequate. Considering the causal importance of LDL for the pathogenesis of atherosclerosis, epidemiological evidence and the clear genetic association of LDL-C with cardiovascular risk as well as the large statin trials and the reduction of events by a non-statin intervention in the IMPROVE-IT study, the term hypothesis appears to be outdated and should be replaced by LDL-causality.

引用

页码：761 / U71

页数：5

共 17 条

[1] Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].

Baigent, C ;

Keech, A ;

Kearney, PM ;

Blackwell, L ;

Buck, G ;

Pollicino, C ;

Kirby, A ;

Sourjina, T ;

Peto, R ;

Collins, R ;

Simes, J .

LANCET, 2005, 366 (9493) :1267-1278

[2] Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: Final baseline characteristics of the IMPROVE-IT study population [J].

Blazing, Michael A. ;

Giugliano, Robert P. ;

Cannon, Christopher P. ;

Musliner, Thomas A. ;

Tershakovec, Andrew M. ;

White, Jennifer A. ;

Reist, Craig ;

McCagg, Amy ;

Braunwald, Eugene ;

Califf, Robert M. .

AMERICAN HEART JOURNAL, 2014, 168 (02) :205-+

[3] Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events A Meta-Analysis of Statin Trials [J].

Boekholdt, S. Matthijs ;

Hovingh, G. Kees ;

Mora, Samia ;

Arsenault, Benoit J. ;

Amarenco, Pierre ;

Pedersen, Terje R. ;

LaRosa, John C. ;

Waters, David D. ;

DeMicco, David A. ;

Simes, R. John ;

Keech, Antony C. ;

Colquhoun, David ;

Hitman, Graham A. ;

Betteridge, John ;

Clearfield, Michael B. ;

Downs, John R. ;

Colhoun, Helen M. ;

Gotto, Antonio M., Jr. ;

Ridker, Paul M. ;

Grundy, Scott M. ;

Kastelein, John J. P. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (05) :485-494

[4] Premature Release of Data from Clinical Trials of Ezetimibe [J].

Califf, Robert M. ;

Harrington, Robert A. ;

Blazing, Michael A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (07) :712-717

[5]

Cannon C P, 2014, IMPROVE IT TRIAL COM

[6] Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): Comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes [J].

Cannon, Christopher P. ;

Giugliano, Robert P. ;

Blazing, Michael A. ;

Harrington, Robert A. ;

Peterson, John L. ;

Sisk, Christine McCrary ;

Strony, John ;

Musliner, Thomas A. ;

McCabe, Carolyn H. ;

Veltri, Enrico ;

Braunwald, Eugene ;

Califf, Robert M. .

AMERICAN HEART JOURNAL, 2008, 156 (05) :826-832

[7]

Ference B A, 2015, J AM COLL CARDIOL

[8] Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease A Mendelian Randomization Analysis [J].

Ference, Brian A. ;

Yoo, Wonsuk ;

Alesh, Issa ;

Mahajan, Nitin ;

Mirowska, Karolina K. ;

Mewada, Abhishek ;

Kahn, Joel ;

Afonso, Luis ;

Williams, Kim Allan, Sr. ;

Flack, John M. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (25) :2631-2639

[9] SERUM CHOLESTEROL, LIPOPROTEINS, AND RISK OF CORONARY HEART DISEASE - FRAMINGHAM STUDY [J].

KANNEL, WB ;

CASTELLI, WP ;

GORDON, T ;

MCNAMARA, PM .

ANNALS OF INTERNAL MEDICINE, 1971, 74 (01) :1-+

[10] Familial Hypercholesterolemia: Developments in Diagnosis and Treatment [J].

Klose, Gerald ;

Laufs, Ulrich ;

Maerz, Winfried ;

Windler, Eberhard .

DEUTSCHES ARZTEBLATT INTERNATIONAL, 2014, 111 (31-32) :523-+

← 1 2 →